Cal Sale Delayed Amid Regulatory Review

The planned divestiture of Cal, a prominent Israeli credit card company, faces an indefinite postponement as governmental bodies signal a willingness to grant an extension. This development follows the definitive collapse of the acquisition deal with Union Group, led by George Horesh, and Harel Insurance. The original deadline for Bank Discount, Cal's parent entity, to complete the sale was set for April 2027, a timeline now under review.

Sources indicate that both the Supervisor of Banks at the Bank of Israel and the Ministry of Finance are leaning towards approving a delay. This potential extension is contingent upon a thorough review of several factors, including the duration of the market's engagement since the sale process commenced and the initial interest generated. The protracted nature of the regulatory review by the Competition Authority, which reportedly extended for nearly a year, is also being considered as a significant factor in favor of an extension for Bank Discount.

Market observers suggest that the stringent conditions imposed by the Competition Authority, such as requiring Union Group to divest its holdings in Super-Pharm, were strategically designed to steer the process towards an initial public offering (IPO) for Cal. This perspective implies that any future transaction involving Cal might encounter similar regulatory hurdles, potentially complicating direct sales to strategic buyers.

The broader implications of this delay extend to the evolving landscape of Israel's financial services sector. Historically, credit card companies have been predominantly owned by major banking institutions. However, recent years have seen a shift, with insurance companies and private investment groups expressing increased interest. This trend has sparked public debate regarding the concentration of power within the financial industry and the need for diverse ownership structures that can offer genuine alternatives to established market players.

The failed acquisition by Union Group and Harel Insurance represents a significant setback, not only for Bank Discount but also for the potential acquirers who had committed substantial resources to the transaction. The collapse of the deal necessitates a recalibration of strategy for all parties involved, with Bank Discount now needing to navigate a more complex path to divestment, potentially through an IPO or by seeking alternative buyers under revised market conditions.

This situation underscores the intricate regulatory environment governing major financial asset sales in Israel. The Competition Authority's role in shaping market dynamics is evident, as its interventions can significantly alter the feasibility and structure of proposed transactions. The government's consideration of an extension highlights a pragmatic approach, acknowledging the challenges posed by regulatory scrutiny and market conditions in achieving a successful divestiture.